Selvarajah V, Robertson D, Hansen L, Jermutus L, et al. A randomized phase 2b trial examined the effects of the glucagon-like peptide-1 and glucagon receptor agonist cotadutide on kidney outcomes in patients with diabetic kidney disease. Kidney Int 2024 Aug 30:S0085-2538(24)00629-X. doi: 10.1016/j.kint.2024.
PMID: 39218393